The popularity of GLP-1 medications like Ozempic, Wegovy, and Mounjaro has exploded in recent years. With brand-name versions often expensive and hard to access, many people are turning to online providers, telehealth platforms, and medical spas. A recent poll of over 1,300 Americans found that roughly one in four people taking these drugs obtain them from these alternative sources rather than from their primary care doctor or a specialist.
While these options can offer lower prices and greater convenience, experts caution that they come with significantly less oversight and real safety concerns. A recent New Tork Times article spells out some of the factors to consider.
